Lactazole A is a cryptic thiopeptide from Streptomyces lactacystinaeus, encoded by a compact 9.8 kb 27 biosynthetic gene cluster. Here, we established a platform for in vitro biosynthesis of lactazole A, 28 referred to as the FIT - Laz system, via a combination of the flexible in vitro translation (FIT) system 29 with recombinantly produced lactazole biosynthetic enzymes. Systematic dissection of lactazole 30 biosynthesis revealed remarkable substrate tolerance of the biosynthetic enzymes, and led to the 31 development of the "minimal lactazole scaffold", a construct requiring only 6 post-translational 32 modifications for macrocyclization. Efficient assembly of such minimal thiopeptides with FIT-Laz 33 enabled access to diverse lactazole analogs with 10 consecutive mutations, 14-to 62-membered 34 macrocycles, and up to 18 amino acid-long tail regions. Moreover, utilizing genetic code 35 reprogramming, we demonstrated synthesis of pseudo-natural lactazoles containing 4 non-36 proteinogenic amino acids. This work opens possibilities in exploring novel sequence space of pseudo-37 natural thiopeptides. 38 39 595
Introduction 40
Thiopeptides are natural products defined by a six-membered nitrogenous heterocycle, usually 41 pyridine, grafted within the backbone of a peptidic macrocycle. 1 Multiple azole rings, dehydroamino 42 acids, and other optional nonproteinogenic elements further contribute to the resulting structural 43 complexity characteristic of thiopeptides. More than a hundred thiopeptides isolated to date are defined 44 by strong antibiotic activity against Gram-positive bacteria, including methicillin resistant 45 Staphyrococcus aureus (MRSA). 1-3 For instance, thiostrepton has been used as a topical antibiotic in 46 veterinary medicine, and LFF571, a synthetic derivative of naturally occurring GE2270A, underwent 47 clinical trials as a treatment against Clostridium difficile infections. 4 48 A decade ago, thiopeptides were shown to be of ribosomal origin. [5] [6] [7] [8] During biosynthesis, a structural 49 gene encoding a thiopeptide precursor is transcribed and translated, and the resulting peptide undergoes 50 post-translational modifications (PTMs) introduced by cognate enzymes colocalized with the structural 51 gene in a biosynthetic gene cluster (BGC). Commonly, these enzymes utilize the N-terminal leader 52 peptide (LP) region of the precursor as a recognition sequence, and act on the core peptide (CP) to 53 introduce PTMs such as azole and dehydroalanine (Dha). Eventually, a pyridine synthase catalyzes 54 formation of a six-membered heterocycle in the CP and eliminates the LP, yielding a macrocyclic 55 thiopeptide. Thus, thiopeptides represent a group of ribosomally synthesized and post-translationally 56 modified peptide (RiPP) natural products. 9 57 RiPP biosynthetic logic is highly conducive to bioengineering. 10, 11 Simple nucleotide substitutions 58 in the structural gene yield novel compounds, provided that these mutations are tolerated by the 59 biosynthetic machinery. For BGCs encoding promiscuous enzymes, e.g. lanthipeptides and 60 cyanobactins, this strategy can be applied to construct combinatorial libraries of natural product analogs. 61 Recent studies demonstrated that such libraries can be screened to improve or completely reprogram 62 antibacterial activities of the underlying RiPPs. 12-19 63 In contrast, thiopeptide bioengineering proved to be significantly more challenging. Single-point 64 mutagenesis studies 20-24 and a few complementary reports (e.g., BGC minimization, 25 and an 65 incorporation of a single non-proteinogenic amino acid (npAA) suitable for bioconjugation) 26 represent 66 the bulk of the work on this topic. The challenges in thiopeptide bioengineering can be attributed to a 67
highly cooperative yet only partially understood biosynthesis process. For many thiopeptides, the roles 68 of individual biosynthetic enzymes are only beginning to be elucidated. [27] [28] [29] [30] [31] Chemoenzymatic and 69 semisynthetic approaches 32-38 may circumvent the limitations imposed by biosynthetic machinery, but 70 due to the structural complexity of thiopeptides, these strategies present a number of challenges of their 71 own. 72 We previously reported isolation and characterization of lactazole A, a cryptic thiopeptide from 73
Streptomyces lactacystinaeus (Fig. 1a) . 39 It is biosynthesized from a compact 9.8 kb laz BGC encoding 74 just five enzymes essential for the macrocycle formation ( Fig. 1b) . Lactazole A has a low Cys/Ser/Thr 75 content, a 32-membered macrocycle, and bears an unmodified amino acid in position 2 (Trp2), all of 76 which are unusual features among thiopeptides ( Fig. 1c) . 40 Moreover, lactazole A shows no antibacterial 77 4 activity, and its primary biological function remains unknown. Recent bioinformatic studies indicated 78 that the lactazole-like thiopeptides, characterized by an unmodified amino acid in position 2, comprise 79 close to half of all predicted thiopeptides (251 out of 508 annotated BGCs), and yet the prototypical laz 80 BGC remains the only characterized member of this family to date. 41 Overall, lactazole-like thiopeptides 81 remain a rather enigmatic family of natural products, as close to nothing is known about their function, 82 structural diversity, and biosynthesis. 83
Intrigued by the uniqueness of laz BGC, we set out to reconstitute in vitro biosynthesis of lactazole A. 84 We sought to establish rapid and reliable access to lactazole A and its analogs in order to evaluate the 85 applicability of laz BGC for bioengineering, and to pave the way for future characterization of enzymes 86 and BGCs from the lactazole family. To this end, we report construction of the FIT-Laz system, a 87 combination of flexible in vitro translation (FIT) 42 with PTM enzymes from laz BGC, as a platform for 88 facile in vitro synthesis of lactazole-like thiopeptides (Fig. 1d) . Taking advantage of the FIT-Laz system, 89
we explored the substrate plasticity of laz BGC, and found that in vitro lactazole biosynthesis is 90 remarkably tolerant to mutation, insertion and deletion of multiple amino acids, including npAAs. A 91 systematic dissection of the pathway led to the identification of the "minimal lactazole scaffold", a CP 92 with only 5 amino acids indispensable for the macrocyclization process. Our work opens a possibility 93 to tap into an unexplored sequence space of pseudo-natural thiopeptides, and use them as molecular 94 scaffolds in drug lead discovery against protein targets of choice. 95
Results

96
In vitro reconstitution of lactazole biosynthesis 97
We began with recombinant production of Laz enzymes in Escherichia coli BL21(DE3). The five 98 enzymes (LazB, LazC, LazD, LazE, and LazF) were expressed and purified as soluble His-tagged 99 proteins (Fig. S1 ). The FIT system was used to establish access to the precursor peptide (LazA; 43 Fig.  100 2a). Linear DNA template encoding LazA was assembled by PCR and incubated with the in vitro 101 reconstituted translation machinery from E. coli supplemented with T7 RNA polymerase. This scheme 102 for precursor peptide production parallels the previously established FIT-PatD and FIT-GS systems, 103 used for the synthesis of azoline-containing peptides 44 and goadsporin analogs 45 , respectively. 104 With all components in hand, we turned to reconstitution of lactazole biosynthesis. Maturation of 105 goadsporin, a distantly related linear azole-containing RiPP, is initiated with the formation of azoles, 106 while Dha installation is dependent on it, 46 and biosynthesis of thiomuracin also follows a similar 107 modification order. 47 Based on these results, we hypothesized that azole formation is the starting point 108 in lactazole biosynthesis, and therefore attempted to reconstitute the activity of LazDEF (LazD, LazE 109 and LazF) first. LazDE is a split YcaO cyclodehydratase 40,48 characteristic of thiopeptide BGCs: LazD 110 is predicted to bear a RiPPs recognition element, necessary for LP binding, 49 and LazE contains an 111 ATP-binding domain, 50 utilized for ATP-dependent cyclodehydration of Cys/Ser residues in the CP (Fig.  112   1d) . LazF is an unusual bifunctional protein that features a fusion between an FMN-dependent 113 dehydrogenase which oxidizes azolines installed by LazDE to azoles, 51-53 and a glutamate elimination 114 domain, tentatively participating in the formation of Dha (see below). After LazA precursor peptide 115 5 expressed with the FIT system ( Fig. 2b) was incubated with LazDE, the mixture was treated with 116 iodoacetamide (IAA) and analyzed by LC-MS. The resulting broad-range extracted ion chromatogram 117 ( br EIC; see S.I. 2.10 and Fig. S2 -S5 for detailed description of br EIC) indicated that the LazDE reaction 118 yielded a mixture of two, three, four and five dehydrations ( Fig. 2c) . Either LazD or LazE alone had no 119 activity ( Fig. S6a and b) . In contrast, incubating LazA with LazDEF afforded a single product 120 containing 4 azoles ( Fig. 2d) . No alkylation occurred on this peptide by IAA suggesting that all Cys 121 residues were cyclized, and MS/MS analysis of this product supported the native azole pattern, i.e. three 122 thiazoles in positions 5, 7, 13 and one oxazole in position 11 ( Fig. S7) . 123 Next, we attempted to reconstitute the Dha-forming activity ( Fig. 1d) . LazBF is a split dehydratase, 124 widely conserved in thiopeptide BGCs (Fig. 1b) . 54, 55 These proteins are homologous to class I 125 lanthipeptide dehydratases, which utilize Glu-tRNA Glu to glutamylate Ser or Thr residues in the CP of 126 a substrate (using the glutamylation domain), 46 and then catalyze elimination of the glutamate to yield 127 Dha (using the elimination domain). In laz BGC, LazB is annotated as a glutamylation domain, and the 128 N-terminal part of LazF is an elimination domain. Even though we assumed that azole formation 129 precedes Dha synthesis, we first attempted to test LazB activity on the unmodified LazA. Surprisingly, 130
LazB glutamylated LazA once when incubated in the presence of synthetic tRNA Glu originating from 131 S. lactacystinaeus and glutamyl-tRNA synthetase (GluRS) from S. lividans ( Fig. 2e) , while reactions 132 lacking any one component led to no modification ( Fig. S6f-h) . These results indicated that like 133 homologous enzymes, 56,57 LazB utilizes Glu-charged tRNA Glu and catalyzes glutamylation of LazA. 134
Because E. coli tRNA Glu and GluRS present in the translation mixture were not accepted, LazB appears 135 to be specific for the Streptomyces tRNA Glu and GluRS. The complete dehydratase activity was 136 reconstituted with the addition of LazF to the mixture, in which case the reaction yielded a singly 137 dehydrated product ( Fig. 2f) . Extending the reaction time led to sluggish second and third dehydrations 138 ( Fig. S6i) . These results indicated that LazBF can catalyze formation of some but not all Dha in LazA 139 independent of azole formation. 140 We next studied whether LazBF forms remaining Dha in an azole-dependent fashion. To this end, 141 we incubated the LazDEF-treated LazA, bearing 4 azoles, with LazBF, tRNA Glu and GluRS. This 142 reaction led to a major product 90 Da lighter than the 4-azole LazA, consistent with the formation of 5 143
Dha, suggesting that all available Ser in the CP were dehydrated (Fig. 2g) . Coincubation of LazA with 144 LazBDEF, tRNA Glu and GluRS resulted in the formation of a complex mixture with the same major 145 product ( Fig. S6j) . 146 Finally, we tested reconstitution of the entire biosynthetic pathway by adding LazC to the reaction. 147
The putative pyridine synthase LazC is weakly homologous to TclM and TbtD, two well-studied 148 enzymes catalyzing analogous reactions. 38, 58 Both enzymes are believed to initiate a [4+2]-149 cycloaddition reaction leading to the formation of a macrocyclic product bearing dihydropyridine, 150 which is further aromatized by eliminating LP as a C-terminal amide (LP-NH2) to give rise to a pyridine 151 ring. Accordingly, incubation of the aforementioned LazA bearing 4 azole/5 Dha with LazC afforded 152 LP-NH2 accompanied by a thiopeptide 18 Da lighter than expected, indicating that Ser4, unmodified in 153 6 lactazole A, was dehydrated (Dha4-lactazole A) ( Fig. 2h and i) . MS/MS analysis of this product 154 confirmed its structure ( Fig. S11) . Lactazole A was a minor product under these reaction conditions. 155
Changing the order of the enzyme addition (LazDEF followed by LazBC, tRNA Glu and GluRS) 156 suppressed the formation of the overdehydrated product, but still, a mixture of thiopeptides formed ( Fig.  157   2j) . In contrast to the stepwise reactions, coincubation of LazA with the full enzyme set (LazBCDEF, 158 tRNA Glu and GluRS) resulted in the formation of lactazole A and LP-NH2 with only a trace amount of 159 Dha4-lactazole A (Fig. 2k) . LC-MS analysis of the in vitro synthesized lactazole A showed that its 160 molecular weight and HPLC retention time were identical to the authentic in vivo synthetized standard 161 ( Fig. S9) . Additionally, both samples had matching, annotatable CID MS/MS spectra ( Fig. S8 and S10) , 162 indicating that the one-pot reaction yielded the authentic thiopeptide. 163
In summary, here we demonstrated that the translation product of lazA accessed with the FIT system 164 can be treated with the full set of Laz enzymes to yield lactazole A. We refer to this series of 165 transformations as the FIT-Laz system. 166
Analysis of substrate tolerance of Laz enzymes 167
To understand the overall substrate plasticity of laz BGC, we next investigated whether the FIT-Laz 168 system can produce lactazole analogs. We commenced with Ala-scanning mutagenesis and prepared 14 169 single-point Ala mutants in the CP region of LazA. The precursor peptides were expressed and modified 170 with the FIT-Laz system, and the reaction outcomes were analyzed by LC-MS as above ( Fig. 3a) . Only 171 4 Ala mutants, S1A, S10A, S11A, and S12A, abolished formation of thiopeptides, whereas other 172 constructs led to the formation of corresponding lactazole analogs and LP-NH2. During maturation, 173
Ser1 and Ser12 are converted to Dha and are then utilized by LazC for pyridine 174 formation/macrocyclization. Moreover, pyridine synthases are known to recognize the modification 175 pattern around the 4π component, 38 which is consistent with the abrogation of biosynthesis in S10A and 176 S11A mutants. On the other hand, C13A mutant was converted to a thiopeptide without modifications 177 in the tail region, suggesting that the Dha10-oxazole11-Dha12 moiety is the minimal recognition motif 178 around the 4π component for the LazC-catalyzed macrocyclization. Significant accumulation of linear 179 side-products and partially processed peptides for W2A and G3A mutants indicates that these amino 180 acids are also important for smooth lactazole biosynthesis. Ala mutants in positions 4-8, 15 and 16, 181 including those disrupting azole and Dha installation, were tolerated, albeit in some cases a mixture of 182 thiopeptides formed ( Fig. S12 and S13) . 183 Intrigued by these results, we examined whether non-essential modifications inside the macrocycle 184 (Ser4-Cys7) can be removed altogether. Indeed, a tetra-Ala mutant, LazA S4-C7A, was converted to a 185 thiopeptide containing just 2 azoles and 1 Dha upon treatment with the full enzyme set (Fig. 3b) . A 186 pentamutant LazA S4-C7A, C13A also afforded a thiopeptide, but at a much lower overall efficiency, 187 as a number of partially processed linear peptides accumulated after overnight treatment ( Fig. S14a) . 188 Based on these results, we concluded that the five residues undergoing PTM in LazA S4-C7A (Ser1, 189 Ser10, Ser11, Ser12 and Cys13) are essential for efficient maturation. We termed the resulting 190 thiopeptide as the minimal lactazole scaffold, and the corresponding precursor peptide as the minimal 7 lactazole precursor (LazA min ). Because in vitro biosynthesis of the minimal lactazole proceeded as 192 efficiently as the wild type, we decided to investigate enzymatic processing of LazA min and its potential 193 for bioengineering applications in more detail. 194 In the next series of experiments, we examined the tolerance of Laz enzymes to the presence of 195 charged amino acids in the CP, and performed Lys-and Glu-scanning of LazA min CP. Charged amino 196 acids are rarely found in CPs of thiopeptides, 39-41 and RiPP enzymes from other classes are also known 197 to disfavor charged amino acids in general, especially negatively charged Asp and Glu close to the 198 modification site. We prepared 11 single-point Lys mutants and 11 single-point Glu mutants in the non-199 essential positions of LazA min and analyzed their processing as above (Fig. S15) . The results of scanning revealed that a positively charged amino acid is well tolerated in 9 out of 11 positions, whereas 201 W2K and A14K mutants suffered from inefficient processing. Glu was less accepted than Lys overall. 202
In addition to inefficient processing of W2E and A14E, mutants Q8E, A9E and P16E also resulted in 203 little to no thiopeptide formation. These data suggest that in addition to the five previously identified 204 amino acids, Trp2 and Ala14 also play an important role in LazA min maturation. 205
Next, we sought to establish the minimal and maximum macrocycle sizes accessible with All known thiopeptides range between 26-(thiocillin, thiostrepton and nosiheptide) and 35-membered 207 macrocycles (berninamycin). 59 Additionally, previously reported bioengineering of thiocillin BGC led 208 to 23-membered artificial variants. 60 Here, we prepared amino acid insertion and deletion variants of 209
LazA min , and, as before, expressed and modified them with the FIT-Laz system. The results of LC-MS 210 analysis are summarized in Fig. 3c . Deletion of up to 3 amino acids between Ser1 and Ser10 was well 211 tolerated, and led to the efficient formation of 29-to 23-membered thiopeptides. The 4-6 amino acid 212 deletion mutants were also competent substrates and yielded 20-to 14-membered macrocycles, but at 213 relatively low overall efficiencies, as a number of partially processed linear peptides accumulated. 214
Formation of an 11-membered thiopeptide (deletion of 7 residues) was not observed. Thus, it appears 215 that 14-membered thiopeptides are the smallest accessible with Laz enzymes, 9 atoms smaller than the 216 previously smallest thiocillin variants. 60 In contrast, no upper limit on the ring size could be placed. All 217 tested substrates were accepted by the enzymes: the largest synthesized product bore a 62-membered 218 macrocycle, which corresponds to a 10 amino acid insertion. The overall processing efficiency 219 decreased linearly with increasing the cycle size; where LazA min itself was efficiently converted to a 220 macrocycle and LP-NH2, substrates with multiple amino acid insertions had substantial accumulation Sequence extension outside of the macrocycle was also easily achievable, as 3 LazA min variants with 226 the C-terminal tail extensions of up to 15 amino acids were efficiently converted to thiopeptides ( Fig.  227   3d and S14b-d) . 228 Encouraged by these results, we examined whether FIT-Laz can accommodate sequence 229 8 randomization inside the macrocycle. We prepared 10 LazA min variants containing 10 consecutively 230 randomized amino acids each, which corresponds to the simultaneous insertion of 3 amino acids and 231 mutation of residues 3-9 in LazA min CP (see S.I. 2.7 for sequence choices). Expression and modification 232 of these peptides by FIT-Laz and the subsequent LC-MS analysis (Fig. 4a ) revealed that 9 out of 10 233 substrates produced thiopeptides as efficiently as LazA min . One substrate (10aa-sub-4) led to the 234 formation of multiple thiopeptides owing to three Ser and Thr residues in the inserted region undergoing 235 differential dehydration (Fig. S16) , and another variant (10aa-sub-10) had major accumulation of 236 partially processed linear peptides, albeit with detectable formation of the thiopeptide. 237
Finally, we combined sequence randomization inside the macrocycle with the C-terminal extension, 238 and constructed a LazA min mutant with a 34 amino acid-long CP. Despite its size, this substrate 239 efficiently generated a 3.7 kDa thiopeptide when treated with Laz enzymes (Fig. 4b, S17) , highlighting 240 the scaffolding ability of key residues in LazA min . 241
Taken together, these data indicate an unprecedented flexibility of laz BGC. Many individual 242 enzymes and entire RiPP pathways are similarly promiscuous, but thiopeptide biosynthesis is usually 243 sensitive to much more modest perturbations. These results point to potential applications of laz BGC 244 in bioengineering. 245
Synthesis of hybrid thiopeptides with FIT-Laz 246
One advantage of the FIT system is its amenability to genetic code reprogramming. Incorporation 247 of multiple npAAs can be achieved by adding appropriate orthogonal tRNAs precharged with npAAs 248 of choice by the use of flexizymes 42 to the translation mixture lacking certain proteinogenic amino acids 249 and cognate aminoacyl-tRNA synthetases. The FIT system was previously used to synthesize peptides 250 containing a variety of npAAs, including D-, β-, N-methylated-, and α,α-disubstituted-amino acids as 251 well as hydroxyacids. 62 Recently, a combination of genetic code reprogramming in the FIT system with 252 a promiscuous RiPP enzyme also enabled synthesis of peptides containing exotic azoline residues. 63 253 Such npAAs are often found in peptidic natural products, both in RiPPs 9 and in non-ribosomally 254 synthesized peptides (NRPs). 64 We reasoned that if LazA precursors containing ribosomally installed 255 npAAs are accepted by Laz enzymes, various "hybrid" thiopeptides may be accessible with the FIT-256
Laz system. 257
We began by testing the ability of FIT-Laz to produce N-methylated thiopeptides, and prepared 12 258 lazA min mutants bearing a single Met codon (AUG) in the CP. The Met codon was reassigned to either 259 N-methylglycine ( Me Gly) or N-methylalanine ( Me Ala) by expressing these genes from a Met-depleted 260 translation mixture in the presence of precharged Me Gly-tRNACAU or Me Ala-tRNACAU (see S.I. 2.8 for 261 details). Treatment of these translation products with the full enzyme set ( Me Gly-and Me Ala-scanning 262 mutagenesis) and the subsequent LC-MS analysis revealed that, similarly to the results of Lys/Glu-263
scanning, either of the tested N-methylated amino acid was easily accepted in 9 positions, while 264 mutations at Trp2, Cys13 and Ala14 were detrimental, affording little to no mature thiopeptide (Fig.  265   S18) . 266 Next, we tested whether more diverse npAAs can be incorporated into the thiopeptide scaffold 267 9 following the same logic. For this study, we focused on lazA min bearing the AUG codon in position 5, 268 and analogous to the experiments above, prepared LazA min variants containing D-Ala, D-Ser, 269 cycloleucine (cLeu), pentafluorophenylalanine (Phe(F5)), 5-hydroxy-tryptophan (Trp(5-OH)), lactic 270 acid ( HO Ala), β-Met, and β-homoleucine (β-hLeu). All of these substrates were smoothly converted to 271 the corresponding thiopeptides by the action of Laz enzymes, affording hybrid thiopeptides containing 272 a variety of npAAs (Fig. 5a) . 273 Finally, we studied whether multiple different npAAs can be simultaneously incorporated into the 274 minimal lactazole scaffold to generate highly artificial "pseudo-natural" macrocycles. Due to the 275 presence of a 38-residue LP in LazA min , the codon boxes available for reprogramming are limited (see 276 S.I. 2.8 for details). After some experimentation, we opted to reprogram four codons (AAG, CAU, UGG 277 and UUU), and reassigned them as Me Gly, cLeu, Phe(F5) and Me Ala, respectively. To this end, a DNA 278 template encoding lazA min with 4 codons of interest ( Fig. 5b and 5c ) was incubated in a 279 Lys/His/Phe/Trp-depleted translation reaction with Me Gly-tRNACUU, Me Ala-tRNAAAA, cLeu-tRNAGUG, 280 and Phe(F5)-tRNACCA to yield a LazA precursor peptide bearing 4 npAAs. Treating this substrate with 281 LazBDEF/tRNA Glu /GluRS afforded a fully processed linear precursor bearing 2 azoles and 3 Dha (Fig.  282   S19) , while the reaction utilizing the full enzyme set led to the formation of the predicted thiopeptide 283 accompanied by LP-NH2 (Fig. 5d) . The identities of this macrocycle and its linear precursor were 284 confirmed by CID MS/MS analysis ( Fig. S19 and S20) . From these experiments, we conclude that the 285 FIT-Laz system offers facile access to previously inaccessible hybrid thiopeptides, including novel 286 heavily modified pseudo-natural architectures. These results additionally underscore the promiscuity of 287
Laz enzymes, as all tested substrates containing disruptive amino acids outside of the canonical 288
Ramachandran space were efficiently converted to mature thiopeptides. 289
Discussion
290
In this study, we completed in vitro reconstitution of laz BGC, which is responsible for biosynthesis 291 of lactazole A, a cryptic thiopeptide from S. lactacystinaeus. This is the first in vitro reconstitution of 292 an entire thiopeptide BGC, and the second reconstitution of biosynthetic enzymes involved in the 293 formation of a primary thiopeptide macrocycle. 65 The FIT-Laz system established in this study enabled 294 rapid access to numerous LazA variants; the entire workflow from PCR assembly of lazA DNA 295 templates to LC-MS analysis of reaction outcomes fits within two working days. An added benefit of 296 working with an in vitro reconstituted BGC is the ability to decouple self-immunity, export and 297 proteolytic stability issues, so often complicating in vivo studies, from direct assaying of enzymatic 298 activities. Conversely, in vitro experiments provide no insight into in vivo fates and metabolism of the 299 underlying natural product, and thus, should be interpreted accordingly. 300
The results presented here indicate that all Laz enzymes tolerate substantial disruptions in the 301 structure of the precursor peptide (Fig. 6a) , which stands in contrast to other thiopeptide BGCs 302 characterized to date. Out of 102 structurally diverse precursor peptides tested in this work, 92 yielded 303 lactazole-like thiopeptides, 73 of which were accessed with efficiencies comparable to wild type 304 lactazole A (Table S8 ). How the enzymes manage to properly modify such a diverse set of substrates 305 10 remains to be demonstrated. For now, it is apparent that Laz enzymes are highly cooperative. For 306 instance, addition of LazF to LazDE orchestrates efficient cyclodehydrations ( Fig. 2c vs. Fig. 2d) , LazC 307 prevents overdehydration by LazBF ( Fig. 2h vs. Fig. 2j) , and unaminoacylated S. lactacystinaeus 308 tRNA Glu somehow affects azole formation mediated by LazDEF in the presence of LazB (Fig. S6e vs.  309   Fig. 2d and S6c-d) . Combined with the fact that some Dha can form independent from azole 310 installation, it is likely that the biosynthetic mechanism is more elaborate than the "azoles form first, 311
Dha second" paradigm observed during thiomuracin biosynthesis 47 and frequently assumed for other 312
RiPPs. Investigations into the nature of this cooperativity are a subject of our ongoing studies. 313
Broad substrate scope of Laz enzymes enabled development of the minimal lactazole scaffold ( Fig.  314   6a and b) . This thiopeptide requires only 6 PTM events (formation of 2 azoles, 3 Dha and a pyridine 315 heterocycle) for macrocyclization, and is biosynthetically the simplest known thiopeptide to date. The 316 5 amino acids undergoing these modifications -Ser1, Ser10, Ser11, Ser12 and Cys13 -are 317 indispensable for efficient macrocycle assembly, and further experiments demonstrated that the residues 318 adjacent to the modification sites, Trp2 and Ala14, are also important for efficient biosynthesis. 319
Remaining positions (3-9, 15, 16) accept a variety of amino acids, including disruptive npAAs. 320
Modification of minimal lactazole precursor, LazA min , in the FIT-Laz system is robust, and tolerates 321 massive sequence variations. Specifically, the macrocycle can be contracted or expanded to synthesize 322 14-to 62-membered thiopeptides (2 to 18 unmodified amino acids inside the macrocycle; Fig. 6c and  323   6d) , and the variants with up to 18 amino acid-long tails are accessible as well (Fig. 6e) . Most 324 importantly, LazA min can accommodate mutations of consecutive amino acids, as demonstrated by the 325 synthesis of thiopeptides with 10 randomized amino acids inside the macrocycle (Fig. 6e) . 326 This flexibility of the lactazole biosynthetic machinery, combined with the minimal size of laz BGC, 327 which contains only the genes essential for macrocyclization, suggest that the minimal thiopeptide 328 scaffold may be an excellent candidate for bioengineering. Because continuous randomized epitopes 329 can be displayed inside a thiopeptide backbone, we envision that combinatorial libraries based on this 330 scaffold can be generated and screened akin to the recent reports on lanthipeptide bioengineering. 12-16 331 In those cases, lanthipeptide libraries were prepared with the use of promiscuous lanthipeptide synthases, 332 and could be screened against a protein target of interest with the use of phage/yeast display or with the 333 reverse two-hybrid system. These studies resulted in the discovery of lanthipeptide inhibitors of HIV 334 budding process, 15 urokinase plasminogen activator 16 and αvβ3 integrin binders. 13 Similarly, we 335 anticipate that the integration of the FIT-Laz system with powerful in vitro screening techniques such 336 as mRNA display 66 will provide access to artificial thiopeptides with desirable pharmacological profiles 337 for drug discovery purposes. Displayed are LC-MS chromatograms ( br EIC chromatograms on the left showing partially processed 555 linear peptides and LP-NH2 after enzymatic treatment, and nr EIC chromatograms on the right for 556 expected thiopeptides generated at m/z 0.10 tolerance window). For mutants highlighted in light blue 557 biosynthesis proceeded efficiently; yellow highlighting indicates inefficient thiopeptide formation 558 accompanied by the accumulation of linear intermediates and side-products; red -mutants that failed 559 to yield a detectable thiopeptide. Peaks denoted with an asterisk (*) indicate translation side-products. 560
Mutants C5A and S6A gave 4 and 2 thiopeptides, respectively, annotations of which can be found in 561 as in (a) for the enzymatic processing of the LazA min variant from (c), and the chemical structure of the 592 resulting thiopeptide. Taken together, these data suggest that diverse hybrid pseudo-natural thiopeptides 593 are accessible with the FIT-Laz system. 594
